Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$78,000 |
 |
AmarinAMRN |
$520,000 |
 |
Gilead SciencesGILD |
-$2B |
 |
Anavex Life SciencesAVXL |
-$6.3M |
 |
AmgenAMGN |
-$109M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Tross Stuart A | Jan 8, 2026 | Sell | 47,006 | $6.33 | $300,000 |
| Castagna Michael | Dec 17, 2025 | Sell | 65,804 | $6.01 | $400,000 |
| Castagna Michael | Dec 16, 2025 | Sell | 21,310 | $6 | $130,000 |
| Castagna Michael | Dec 12, 2025 | Sell | 20,806 | $6 | $120,000 |
| Castagna Michael | Dec 2, 2025 | Sell | 107,920 | $5.57 | $600,000 |
| Thomson David | Dec 2, 2025 | Sell | 147,780 | $5.57 | $820,000 |
| Singh Sanjay R | Nov 14, 2025 | Sell | 18,777 | $5.03 | $94,000 |
| Tross Stuart A | Sep 16, 2025 | Sell | 47,000 | $5.34 | $250,000 |
| Binder Steven B. | Jul 16, 2025 | Sell | 75,367 | $3.94 | $300,000 |
| Thomson David | Jul 16, 2025 | Sell | 7,466 | $3.94 | $29,000 |
| Binder Steven B. | Jun 10, 2025 | Sell | 64,085 | $4 | $260,000 |
| Binder Steven B. | May 20, 2025 | Sell | 12,078 | $4.4 | $53,000 |
| Thomson David | May 20, 2025 | Sell | 2,345 | $4.41 | $10,000 |
| Thomson David | May 13, 2025 | Sell | 32,179 | $4.68 | $150,000 |
| Binder Steven B. | May 13, 2025 | Sell | 80,144 | $4.69 | $380,000 |
| Binder Steven B. | Nov 22, 2024 | Sell | 67,536 | $6.89 | $470,000 |
| Binder Steven B. | Nov 15, 2024 | Sell | 67,539 | $6.76 | $460,000 |
| Tross Stuart A | Nov 6, 2024 | Sell | 55,000 | $7.34 | $400,000 |
| Tross Stuart A | Sep 3, 2024 | Sell | 25,000 | $6.26 | $160,000 |
| Tross Stuart A | Aug 30, 2024 | Sell | 45,000 | $6.33 | $280,000 |
| Tross Stuart A | Aug 30, 2024 | Sell | 35,000 | $6.32 | $220,000 |
| Castagna Michael | Aug 29, 2024 | Sell | 85,106 | $6.3 | $540,000 |
| Binder Steven B. | Aug 29, 2024 | Sell | 5,055 | $5.94 | $30,000 |
| Thomson David | Aug 29, 2024 | Sell | 5,553 | $5.94 | $33,000 |
| Binder Steven B. | Jul 16, 2024 | Sell | 2,836 | $5.93 | $17,000 |
| Thomson David | Jul 16, 2024 | Sell | 3,115 | $5.93 | $18,000 |
| Binder Steven B. | May 21, 2024 | Sell | 25,952 | $4.66 | $120,000 |
| Thomson David | May 21, 2024 | Sell | 23,537 | $4.66 | $110,000 |
| Binder Steven B. | May 13, 2024 | Sell | 3,618 | $4.31 | $16,000 |
| Thomson David | May 13, 2024 | Sell | 3,047 | $4.31 | $13,000 |
FAQ - Insider Transactions
The most recent insider transaction for Mannkind was conducted by Tross Stuart A, who sold 47,006 shares on January 8, 2026 at a price of $6.33 per share.
Binder Steven B. has sold the most MNKD stock in the last 2 years, with a total value of $2.1M.
The total value of insider transactions for Mannkind in the last 2 years is negative, amounting to -$6.8M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Mannkind have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
